Allergan Unlimited Company, formerly Allergan Limited, is an Ireland-based pharmaceutical company. The Company is focused on developing, manufacturing and commercializing branded pharmaceutical, device, biologic, surgical and regenerative medicine products for patients around the world. The Company's products primarily focus on four key therapeutic areas, including medical aesthetics, eye care, central nervous system and gastroenterology.

Employees

Sector

Pharmaceuticals

More about the company

Delayed NYSE			5-day change	1st Jan Change
- ^USD	-.--%		+1.73%	+0.97%

21/10	Allergan Aesthetics presents its latest scientific advances
29/09	Abbvie Through Allergan Aesthetics Receives Health Canada Authorization for Boey for Frown Lines	CI

Market Cap	6.37TCr 5.68TCr 5.25TCr 4.76TCr 8.9TCr 6,04300Cr 9.05TCr 63TCr 25TCr 3,16600Cr 24TCr 23TCr 9,98200Cr	P/E 2018	-8.76x	P/E 2019	-11.9x
Enterprise Value	8.1TCr 7.23TCr 6.68TCr 6.05TCr 11TCr 7,68600Cr 12TCr 80TCr 32TCr 4,02700Cr 30TCr 30TCr 12,69600Cr	EV / Sales 2018	4.24x	EV / Sales 2019	4.98x
Free-Float	99.9%	Yield 2018	2.15%	Yield 2019	1.55%

21/10	Allergan Aesthetics presents its latest scientific advances
29/09	Abbvie Through Allergan Aesthetics Receives Health Canada Authorization for Boey for Frown Lines	CI
17/09	Allergan Aesthetics Presents New Clinical Data Evaluating Skin Quality Improvements in Individuals Taking Medical Weight Loss Medications	CI
15/09	Allergan Aesthetics Introduces the FACTS Principles for Exosome-Based Skincare Technologies	CI
01/09	Allergan Aesthetics Launches Skinmedica Barrier Calming Cream and Ha5 Hydra Collagen Facial Mist	CI
08/04	Allergan Aesthetics Opens New Ami Training Center in Austin	CI
31/03	Allergan Aesthetics Announces Fourth Annual CoolMonth With Deals On CoolSculpting	CI
30/03	Allergan Aesthetics Presents Findings on Safety and Efficacy of Repeat Trenibote Treatments and Data on Medical Weight Loss Aesthetics Patient Behaviors At the 2026 American Academy of Dermatology Meeting	CI
19/03	Allergan Aesthetics Reveals Evolution in Approach to Modern Aesthetic Treatments with Comprehensive Global Survey and New Educational Solutions	CI
04/03	Allergan Aesthetics Shares Medical Weight Loss Data and the Changing Profile of Patients	CI
12/11	Allergan Aesthetics Unveils New Data at 2025 American Society for Dermatologic Surgery Annual Meeting Showcasing Transformative Innovation and Portfolio Excellence	CI
25/25/25	AllAllergan Aesthetics to Showcase Multimodal Treatment Approach and Continued Commitment to Skin Quality At AMWC Dubai	CI
19/25/19	Allergan Aesthetics Unveils Its Newest Hydration Hero	CI

01/24/01	Court Dismisses Class Action Against Biopharmaceutical Company For Failing To Disclose Progress Of Competitor; Second Circuit Affirms Dismissal Of Putative Class Action Against Allergan; Eleventh Circuit Affirms That "Toxic" Lender Qualified As A "Dealer" Under The Exchange Act Due To High-Volume Trading; Delaware Court Of Chancery Invalidates Governance Rights In Stockholder Agreement	AQ
20/22/20	Allergan, an AbbVie Company, to Present New Data from its Eye Care Portfolio at the 2022 American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting	AQ
06/22/06	Allergan, an AbbVie Company, Announces Positive Topline Phase 3 Results Evaluating Investigational Twice-Daily Administration of VUITY 1.25% in Adults with Age-Related Blurry Near Vision	AQ
22/22/22	AbbVie and Allergan Aesthetics to Present New Research Across Dermatology Portfolio at 2022 AAD Annual Meeting	AQ
10/21/10	Allergan - VUITY 1.25%, the First and Only FDA-Approved Eye Drop to Treat Age-Related Blurry near Vision, is Now Available	AQ

Allergan plc Share Price

Stocks

AGN

IE00BY9D5467

Pharmaceuticals

Valuation: Allergan plc

Latest news: Allergan plc

Press Releases: Allergan plc

News in other languages: Allergan plc

Managers and Directors: Allergan plc

Latest insider transactions

Other Pharmaceuticals

Financials

Company Profile

21/10	Allergan Aesthetics présente ses dernières avancées scientifiques
20/21/20	Planète Bourse : La revue de presse du mardi 20 avril 2021
07/20/07	EN DIRECT DES MARCHES : Air France KLM, ArcelorMittal, Legrand, Natixis, Peugeot, Eurofins, Zalando, Facebook...
07/20/07	La Chine repart, mais Washington veille
06/20/06	EN DIRECT DES MARCHES : Danone, Sanofi, Crédit Agricole, Arkema, Neoen, Eurofins, BMW, Novo Nordisk...

Director	Title	Age	Since
Scott Reents BRD	Director/Board Member	-	08/05/2020
Ryan Quigley BRD	Director/Board Member	-	08/05/2020
Andres Rodrigo BRD	Director/Board Member	-	08/05/2020

Date	Insider	Type	Main position	Quantity	% Market Cap.
08/05/20	James D'Arecca	Issuer sale	Controller/Auditor	19,495	0.0059%
08/05/20	Adriane Brown	Issuer sale	Director	2,916	0.0009%
08/05/20	Matthew Walsh	Issuer sale	Chief Financial Officer	67,678	0.0206%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
ALLERGAN PLC	-.--%	+1.73%	-	-	6.37TCr
ELI LILLY AND COMPANY	-2.54%	+1.31%	+55.10%	+120.84%	1,13500Cr
JOHNSON & JOHNSON	-1.42%	+3.23%	+37.07%	+74.26%	64TCr
ABBVIE INC.	+0.16%	+0.08%	+25.14%	+97.36%	50TCr
ROCHE HOLDING AG	-0.31%	+3.09%	+43.92%	+64.55%	38TCr
MERCK & CO., INC.	-1.34%	-0.47%	+66.63%	+40.56%	36TCr
NOVARTIS AG	-0.68%	+2.65%	+22.46%	+51.48%	29TCr
ASTRAZENECA PLC	-1.20%	+3.04%	+2.62%	+26.97%	27TCr
AMGEN INC.	-1.79%	+1.57%	+49.97%	+60.87%	24TCr
GILEAD SCIENCES, INC.	-0.73%	-0.10%	+29.24%	+101.19%	19TCr
Average	-0.60%	+2.12%	+36.91%	+70.90%	40.68TCr
Weighted average by Cap.	-0.25%	+2.65%	+40.99%	+82.13%

	2018	2019
Net sales	1.58TCr 1.41TCr 1.3TCr 1.18TCr 2.21TCr 1,49900Cr 2.24TCr 16TCr 6.2TCr 79TCr 5.92TCr 5.8TCr 2,47600Cr	1.61TCr 1.44TCr 1.33TCr 1.2TCr 2.25TCr 1,52700Cr 2.29TCr 16TCr 6.32TCr 80TCr 6.04TCr 5.91TCr 2,52300Cr
Net income	-509.64Cr -455.11Cr -420.43Cr -381.01Cr -712.81Cr -48TCr -724.61Cr -5.06TCr -2TCr -25TCr -1.91TCr -1.87TCr -80TCr	-527.1Cr -470.7Cr -434.84Cr -394.06Cr -737.23Cr -50TCr -749.43Cr -5.23TCr -2.07TCr -26TCr -1.98TCr -1.94TCr -83TCr
Net Debt	2.19TCr 1.95TCr 1.81TCr 1.64TCr 3.06TCr 2,07800Cr 3.11TCr 22TCr 8.6TCr 1,08900Cr 8.22TCr 8.04TCr 3,43300Cr	1.73TCr 1.55TCr 1.43TCr 1.29TCr 2.42TCr 1,64300Cr 2.46TCr 17TCr 6.8TCr 86TCr 6.49TCr 6.36TCr 2,71300Cr